Drugs prescribed and adverse drug reaction monitoring in skin diseases

Authors

  • Maham Ashraf Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan
  • Huma Mahmood Ali Hospital Pharmacist, THQ Hospital Tandlianwala, Government of Punjab, Pakistan
  • Saba Niaz Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan
  • Moater Batool Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan
  • Fauzia Rehman Lecturer, The University of Faisalabad, Pakistan
  • Ifra Nabi Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Pakistan

DOI:

https://doi.org/10.56770/jcp2019325

Keywords:

Drugs prescription, Adverse drug reaction, Monitoring, Skin diseases

Abstract

Background: Skin diseases are more common due to bacteria and fungi, mostly antibiotics, antifungal, NSAIDs, corticosteroids, antipsoriatics and antiacne agents are prescribed. 10% of hospital admissions are due to these ADRs
that include anaphylactic shock, hypersensitivity reactions. Monitoring of ADRs associated with the use of these drugs can be monitored by various ways including spontaneous reporting, yellow card scheme, direct patient reporting, and case control and cohort studies. Method: It is a retrospective study conducted by reviewing research
articles and journals like Journal American Medical Association, JAMA, American Society of Health System Pharmacists, MedCare etc. relating to skin diseases and ADR monitoring relating to use of drugs for treatment from
1969 to 2016. Conclusion: Most prevalent skin diseases are acne, microbial infections, psoriasis, hypersensitivity
reactions, fungal infections and drug used for their treatment results in various adverse drug reactions which should be monitored during the therapy. These ADRs may be associated with minor to life threatening conditions.

Downloads

Published

31.01.2020

How to Cite

1.
Ashraf M, Ali HM, Niaz S, Batool M, Rehman F, Nabi I. Drugs prescribed and adverse drug reaction monitoring in skin diseases. JCP [Internet]. 2020 Jan. 31 [cited 2024 Dec. 4];3(2):65-74. Available from: https://ammanif.com/journal/jcp/index.php/home/article/view/63